• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Blood pressure monitoring toilet Casana lands $30M

Share:

January 31, 2022

Casana, a startup building a heart health-monitoring toilet seat, landed $30 million in Series B funding. Morningside led the round with participation from Matrix Partners, General Catalyst and Outsiders Fund.

This news comes roughly a year after the company announced its $14 million Series A funding round. As of today, the company boasts $46 million in capital.

WHAT THEY DO

The company developed the Heart Seat, a toilet seat that is able to capture health metrics over time. The seat is designed to measure a person’s blood oxygen level, blood pressure and heart rate. This data is sent to a care team’s dashboard, along with overall trends about a patient’s health over time.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The device is also able to send a notification to care providers when a patient’s metrics are outside of the care team’s set parameters. Currently the company is pursuing an FDA clearance for the device. The company is pitching the toilet seat as the first “cuffless blood pressure monitor built into the toilet seat.”

In 2019, the company published data in JMIR that demonstrated the product’s clinical grade accuracy for measurements of blood pressure, stroke volume and blood oxygenation when compared to the clinical gold standard.

WHAT IT’S FOR

The startup plans to use the new funds to fuel its FDA submission and bring the device to market in 2022.

“The Heart Seat is different from virtually every other vitals monitoring product, in that it takes no time out of your day and works best when you forget it’s even there,” Casana CEO Austin McChord said in a statement.

THE LARGER TREND

This isn’t the only system looking to monitor a patient’s blood pressure without a cuff. Swiss company Aktiia landed $17.5 million in November for its blood pressure monitoring bracelet.

Tech giant Samsung has also released a smart watch with blood pressure measurement capabilities. Additionally Omron Healthcare rolled out a wearable oscillometric wrist watch that measures blood pressure called the HeartGuide wristwatch.

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Genesis Biotechnology Group Acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its Portfolio of Preclinical ServicesGenesis Biotechnology Group Acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its Portfolio of Preclinical Services
  • Quest Diagnostics Completes Acquisition of U.S. Laboratory Services Business of Oxford ImmunotecQuest Diagnostics Completes Acquisition of U.S. Laboratory Services Business of Oxford Immunotec
  • Lumeon Appoints CFO, Chairman, MaxQ AI Brings on New Tech Lead and More Digital Health HiresLumeon Appoints CFO, Chairman, MaxQ AI Brings on New Tech Lead and More Digital Health Hires
  • Purdue Pharma, Accused Of Fueling Opioid Crisis, Files For Chapter 11Purdue Pharma, Accused Of Fueling Opioid Crisis, Files For Chapter 11
  • LifeShield announces agreement to acquire IAC, an Oklahoma City-based insurance companyLifeShield announces agreement to acquire IAC, an Oklahoma City-based insurance company
  • Varian Completes Acquisition of Cancer Treatment Services InternationalVarian Completes Acquisition of Cancer Treatment Services International
  • Cardio Diagnostics up 5.5%, Enters $11.2M Financing AgreementCardio Diagnostics up 5.5%, Enters $11.2M Financing Agreement
  • Cynosure Acquires Palomar Medical TechnologiesCynosure Acquires Palomar Medical Technologies

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications